FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia - Summary - MDSpire

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.

  • By

  • Conexiant News Staff

  • January 4, 2026

  • 2 min

Share

Objective:

To announce the FDA clearance of the first daily disposable soft contact lens for presbyopia using extended depth of focus technology.

Approach:
    Key Findings:
    • Deseyne offers a depth of focus comparable to FDA-approved EDOF intraocular lenses.
    • Clinically meaningful improvements in near and intermediate vision have been reported.
    • The lens is manufactured from vifilcon C hydrogel and includes components for hydration and comfort.
    Interpretation:

    The introduction of Deseyne represents a significant advancement in non-surgical options for managing presbyopia, potentially improving patient quality of life.

    Limitations:
    • The article does not provide specific clinical trial data or outcomes from US-based studies.
    • Long-term effects and performance in diverse populations are yet to be established.
    Conclusion:

    Deseyne's FDA clearance marks a pivotal development in presbyopia management, expanding options for patients seeking non-surgical solutions.

Original Source(s)

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

  • by Conexiant News Staff

  • January 4, 2026

Related Content

From Minus Fours to Major Gains

Dr. William Stephen discusses growing your practice with myopia management.

Success and Failure Rates with Increased-Range-of-Focus IOLs 

IRoF lenses offer high success, with some outperforming others

No-Fee CE: Specialty Lens Matchmaking 101

This no-fee CE article reviews the multiple factors that a practitioner should consider when fitting specialty contact lenses in order to optimize visual outcomes, patient comfort, and ocular health.